Jay Luly
Chief Executive Officer chez ENANTA PHARMACEUTICALS, INC.
Fortune : 14 M $ au 31/03/2024
Profil
Jay R.
Luly is the President, Chief Executive Officer & Director of Enanta Pharmaceuticals, Inc. He previously held positions as Director at Artesian Therapeutics, Inc., SVP-Drug Discovery & Pre-Clinical Development at Abbott Laboratories, Senior VP-Research & Development Operations at Millennium Pharmaceuticals, Inc., and Senior VP-Drug Discovery & Preclinical Development at LeukoSite, Inc. He also served as a Trustee at The Boston Biomedical Research Institute.
Luly holds a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Illinois.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/02/2024 | 810 609 ( 3,83% ) | 14 M $ | 31/03/2024 |
Postes actifs de Jay Luly
| Sociétés | Poste | Début |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Chief Executive Officer | 01/07/2003 |
Anciens postes connus de Jay Luly
| Sociétés | Poste | Fin |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
| The Boston Biomedical Research Institute | Director/Board Member | - |
Artesian Therapeutics, Inc.
 Artesian Therapeutics, Inc. BiotechnologyHealth Technology Artesian Therapeutics, Inc. develops and manufactures biopharmaceutical therapeutic products. Its products are used for the treatment of cardiovascular and other life threat diseases. The company was founded by Peter D. Suzdak in March 2002 and is located in Gaithersburg, MD | Director/Board Member | - |
Formation de Jay Luly
| University of California, Berkeley | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Health Technology |
Artesian Therapeutics, Inc.
Artesian Therapeutics, Inc. BiotechnologyHealth Technology Artesian Therapeutics, Inc. develops and manufactures biopharmaceutical therapeutic products. Its products are used for the treatment of cardiovascular and other life threat diseases. The company was founded by Peter D. Suzdak in March 2002 and is located in Gaithersburg, MD | Health Technology |
| The Boston Biomedical Research Institute |
